US Patent Issued to MIRA DX on May 13 for "Biomarkers for predicting tumor response to and toxicity of immunotherapy" (California Inventor)

ALEXANDRIA, Va., June 12 -- United States Patent no. 12,297,509, issued on May 13, was assigned to MIRA DX INC. (Los Angeles).

"Biomarkers for predicting tumor response to and toxicity of immunotherapy" was invented by Joanne Weidhaas (Los Angeles).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention is directed to biomarkers for predicting a patient's response, both therapeutic and toxic, to immunotherapy."

The patent was filed on Feb. 2, 2023, under Application No. 18/163,723.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=1229750...